Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults
暂无分享,去创建一个
C. Matthews | X. Shu | Yu-tang Gao | Y. Xiang | W. Zheng | S. Moore | Xianglan Zhang | Danxia Yu | Yu-Tang Gao | Y. Xiang
[1] X. Shu,et al. Cohort Profile: The Shanghai Men's Health Study. , 2015, International journal of epidemiology.
[2] Sophie V. Eastwood,et al. Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study , 2015, Diabetologia.
[3] Martin E. Fernandez-Zapico,et al. Faculty Opinions recommendation of Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. , 2015 .
[4] Xu Lin,et al. Causes of type 2 diabetes in China. , 2014, The lancet. Diabetes & endocrinology.
[5] Guang Ning,et al. Diabetes in China: a societal solution for a personal challenge. , 2014, The lancet. Diabetes & endocrinology.
[6] C. Lynch,et al. Branched-chain amino acids in metabolic signalling and insulin resistance , 2014, Nature Reviews Endocrinology.
[7] A. Raghavan,et al. Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus , 2014, PloS one.
[8] K. Suhre. Metabolic profiling in diabetes. , 2014, The Journal of endocrinology.
[9] A. Lang,et al. Pharmacological treatment of Parkinson disease: a review. , 2014, JAMA.
[10] Thomas Kocher,et al. 1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. , 2014, The Journal of clinical endocrinology and metabolism.
[11] Wei Zheng,et al. Human metabolic correlates of body mass index , 2013, Metabolomics.
[12] Christian Gieger,et al. Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.
[13] K. Wada,et al. Branched-chain amino acid intake and the risk of diabetes in a Japanese community: the Takayama study. , 2013, American journal of epidemiology.
[14] Jiang He,et al. Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.
[15] T. Foltynie,et al. Exenatide and the treatment of patients with Parkinson's disease. , 2013, The Journal of clinical investigation.
[16] Atul J. Butte,et al. Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response , 2013, Diabetes Care.
[17] Choon Nam Ong,et al. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. , 2013, The Journal of clinical endocrinology and metabolism.
[18] Gabi Kastenmüller,et al. Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance , 2013, Diabetes.
[19] J. Chan,et al. Annals of the New York Academy of Sciences Type 2 Diabetes in East Asians: Similarities and Differences with Populations in Europe and the United States , 2022 .
[20] Wei Zheng,et al. Metabolomics in Epidemiology: Sources of Variability in Metabolite Measurements and Implications , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[21] Wei Jia,et al. Metabolomics in human type 2 diabetes research , 2013, Frontiers of Medicine.
[22] A. Peters,et al. Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.
[23] J. Krieger,et al. BDKRB2 +9/−9 Polymorphism Is Associated with Higher Risk for Diabetes Mellitus in the Brazilian General Population , 2012, Experimental diabetes research.
[24] Christian Gieger,et al. Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.
[25] Olle Korsgren,et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. , 2012, Cell metabolism.
[26] F. Hu,et al. Erythrocyte n-3 fatty acids and metabolic syndrome in middle-aged and older Chinese. , 2012, Journal of Clinical Endocrinology and Metabolism.
[27] H. Tomita,et al. The kallikrein-kinin system in diabetic nephropathy , 2012, Kidney international.
[28] D. Schoepf,et al. Type-2 diabetes mellitus in schizophrenia: Increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up , 2012, European Psychiatry.
[29] An Pan,et al. Rotating Night Shift Work and Risk of Type 2 Diabetes: Two Prospective Cohort Studies in Women , 2011, PLoS medicine.
[30] Trisha Greenhalgh,et al. Risk models and scores for type 2 diabetes: systematic review , 2011, BMJ : British Medical Journal.
[31] P. Marquez,et al. Toward a healthy and harmonious life in China : stemming the rising tide of non-communicable diseases , 2011 .
[32] V. Mootha,et al. Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.
[33] R. DeFronzo. Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes , 2011, Diabetes Care.
[34] J. Stamler,et al. Higher branched-chain amino acid intake is associated with a lower prevalence of being overweight or obese in middle-aged East Asian and Western adults. , 2011, The Journal of nutrition.
[35] M. Schulze,et al. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2011, The American journal of clinical nutrition.
[36] HU FRANKB.,et al. Globalization of Diabetes , 2011, Diabetes Care.
[37] O. Franco,et al. Bidirectional association between depression and type 2 diabetes mellitus in women. , 2010, Archives of internal medicine.
[38] Christian Gieger,et al. Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.
[39] S. Sharp,et al. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. , 2010, The American journal of clinical nutrition.
[40] Andrea Natali,et al. α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.
[41] M. Wahlqvist,et al. Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China. , 2010, Molecular nutrition & food research.
[42] E. Tai,et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men , 2010, Diabetologia.
[43] Corey D. DeHaven,et al. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.
[44] Svati H Shah,et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.
[45] Bo Zhang,et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study , 2008, The Lancet.
[46] T. Miyata,et al. Relationship between serum concentrations of saturated fatty acids and unsaturated fatty acids and the homeostasis model insulin resistance index in Japanese patients with type 2 diabetes mellitus. , 2007, The journal of medical investigation : JMI.
[47] D. English,et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. , 2007, The American journal of clinical nutrition.
[48] Frances S. Turner,et al. Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes , 2006, Nucleic acids research.
[49] N. Rothman,et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. , 2005, American journal of epidemiology.
[50] L. Chao,et al. Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. , 2005, Diabetes.
[51] E. Antunes,et al. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. , 2005, Current medicinal chemistry. Cardiovascular and hematological agents.
[52] Robert A. Harris,et al. Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. , 2004, The Journal of nutrition.
[53] Graeme Eisenhofer,et al. Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans , 2003, Journal of Pharmacology and Experimental Therapeutics.